Diligence memo · auto-generated · as of July 2, 2026
VistaPath Biosystems, Inc.
VistaPath Biosystems, Inc. looks fair against its niche peers and is at-risk on financing cadence.
Businessfiled
VistaPath Biosystems, Inc. operates in Other Technology, based in CAMBRIDGE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
VistaPath Biosystems, Inc. has raised $14M in disclosed capital across 6 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $7.4M on 2022-01-27.
Most recent recorded round closed around 2023-06-22.
Valuation (modeled)modeled
Provath models VistaPath Biosystems, Inc. at approximately $37M (range $5.9M–$102M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.74× the median modeled value of Series A Other Technology companies in 2022–2024 (1325 peers) — value vs value, same stage and era. Within the normal band (74% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 7 months.
Last raise 3.0 yr ago; this sector typically re-raises about every 13 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
The last round stepped up 4.4× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 78% of Other Technology peers (21302 compared).
Modeled value ranks above 50% of those peers.
Closest niche peers: Phylum, Inc., Keon Foundation Ltd., Remoteam Inc., MultiSafe, Inc., Careerian Inc..
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.